Address	Mitsuihanagiri Building, 1/F Tokyo Tokyo 160 Japan
Employees	-
Website	http://www.tella.jp
Updated	09/14/2018
tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It also offers technology and know-how to medical institutions such as university hospitals and national hospitals. It operates through the following business segments: Cell Medicine, Medical Support, and Pharmaceuticals.